Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2026-02-03 @ 9:19 AM
Study NCT ID:
NCT06429150
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Sponsor:
Shenzhen Geno-Immune Medical Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GIMI-IRB-24001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |